Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hider

Showing results (431-440 of 688) with videos related to

Pageof 69
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
High affinity iron(III) scavenging by a novel hexadentate 3-hydroxypyridin-4-one-based dendrimer: synthesis and characterizationTao Zhou, Zu Dong Liu, Hendrik Neubert, et al.
BMC Women'S Health|December 30, 2015
"Why me? I don't fit the mould … I am a freak of nature": a qualitative study of women's experience of goutJane C Richardson, Jennifer Liddle, Christian D Mallen, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 1, 1994
HPLC determination of 1,2-diethyl-3-hydroxypyridin-4-one (CP94), its iron complex [Fe(III) (CP94)3] and glucuronide conjugate [CP94-GLUC] in serum and urine of thalassaemic patientsR O Epemolu, R Ackerman, J B Porter, et al.
Dalton Transactions (Cambridge, England : 2003)|September 10, 2004
A manganese superoxide dismutase mimic based on cis,cis-1,3,5-triaminocyclohexaneElizabeth A Lewis, Hicham H Khodr, Robert C Hider, et al.
Blood|February 1, 1991
The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelatorsC Hershko, E N Theanacho, D T Spira, et al.
BMC Musculoskeletal Disorders|June 9, 2016
A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of goutJane C Richardson, Jennifer Liddle, Christian D Mallen, et al.
BMJ Open|February 13, 2018
Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods studyToby Helliwell, Sara Muller, Samantha L Hider, et al.
Frontiers in Pediatrics|January 31, 2022
Assessing the Utility of an Outpatient Exercise Program for Children With Cystic Fibrosis: A Quality Improvement ProjectDionne Adair, Ahmad Hider, Amy G Filbrun, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|October 1, 1994
Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94P Carthew, A G Smith, R C Hider, et al.
BMC Medicine|August 8, 2019
Antibiotic use and the risk of rheumatoid arthritis: a population-based case-control studyAlyshah Abdul Sultan, Christian Mallen, Sara Muller, et al.
Pageof 69

Showing results (431-440 of 688) with videos related to

Sort By:
Pageof 69
Bioorganic & Medicinal Chemistry Letters|September 13, 2005
High affinity iron(III) scavenging by a novel hexadentate 3-hydroxypyridin-4-one-based dendrimer: synthesis and characterizationTao Zhou, Zu Dong Liu, Hendrik Neubert, et al.
BMC Women'S Health|December 30, 2015
"Why me? I don't fit the mould … I am a freak of nature": a qualitative study of women's experience of goutJane C Richardson, Jennifer Liddle, Christian D Mallen, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 1, 1994
HPLC determination of 1,2-diethyl-3-hydroxypyridin-4-one (CP94), its iron complex [Fe(III) (CP94)3] and glucuronide conjugate [CP94-GLUC] in serum and urine of thalassaemic patientsR O Epemolu, R Ackerman, J B Porter, et al.
Dalton Transactions (Cambridge, England : 2003)|September 10, 2004
A manganese superoxide dismutase mimic based on cis,cis-1,3,5-triaminocyclohexaneElizabeth A Lewis, Hicham H Khodr, Robert C Hider, et al.
Blood|February 1, 1991
The effect of N-alkyl modification on the antimalarial activity of 3-hydroxypyridin-4-one oral iron chelatorsC Hershko, E N Theanacho, D T Spira, et al.
BMC Musculoskeletal Disorders|June 9, 2016
A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of goutJane C Richardson, Jennifer Liddle, Christian D Mallen, et al.
BMJ Open|February 13, 2018
Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods studyToby Helliwell, Sara Muller, Samantha L Hider, et al.
Frontiers in Pediatrics|January 31, 2022
Assessing the Utility of an Outpatient Exercise Program for Children With Cystic Fibrosis: A Quality Improvement ProjectDionne Adair, Ahmad Hider, Amy G Filbrun, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|October 1, 1994
Potentiation of iron accumulation in cardiac myocytes during the treatment of iron overload in gerbils with the hydroxypyridinone iron chelator CP94P Carthew, A G Smith, R C Hider, et al.
BMC Medicine|August 8, 2019
Antibiotic use and the risk of rheumatoid arthritis: a population-based case-control studyAlyshah Abdul Sultan, Christian Mallen, Sara Muller, et al.
Pageof 69